RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
Study sponsor: RedHill Biopharma Limited
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-08-28Actual
Enrollment · participants12Actual
Source updated2025-03-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.